November 2, 2015 5:34pm

 

Pricing in “our’ universe has recently been unsustainable … traders who have been riding the wave also realize that the sector is not going to stay up because it’s safer to sell into strength.

The truth is always hard to handle. Subscription required, read more … http://www.regmedinvestors.com/user/register

 

 

Make RegMed Investors your daily destination. We’ve gathered and sifted through news and share pricing data you need in one convenient spot.

 

 

U.S. stocks closed higher by nearly 1% and more on Monday, the first trading day of November, as investors eyed earnings and a heavy week of economic reports.

The NASDAQ closed UP +73.40 or +1.45% to 5,127.15 and the DOW closed UP +165.22 or +0.94% to 17,828.76.

 

 

Henry’omics:

I hate to be a “kill-joy” when the stem, cell and gene therapy RegMed (SCGT&RM) sector rolls in a sprint upward.  I worry about the lessons learned in the past months – let’s not portend to expect it to stay that way!

  • With financial results being prepared for dissemination in the days ahead – be prepared for a deep breath and a cautious dive in a riptide current.

In my belief, it’s so good it’s bad (or going to be) as the iShares Nasdaq Biotechnology ETF (IBB) jumped more than 3.87% when it had closed Friday DOWN -3.09 or -0.94%.

 

 

A day in the life of the stem, cell and gene therapy RegMed (SCGT & RM) sector:

  • The SCGT & RM equities opened positive with an Advance/Decline line (A/DL) of 32/8 and 3 flats staying positive to the mid-day with an A/DL of 38/3 and 2 flats.  The 3 pm A/DL maintained a strong upside of 38/2 and 3 flats;
  • The closing bell rang positive to end the session with an A/DL of 39/1 and 3 flats.

My fear index, the CBOE Volatility Index (VIX) closed on Monday below 14 from the mid-day’s near 14 following Friday’s near 15.

 

 

Eighteen (18) stocks jumping to the upside - $’s up as compared to Friday’s close:

  • bluebird bio (BLUE) – up +$7.25 having closed down <Friday> -$1.96 ;
  • Cellectis ADR (CLLS) – up +$4.89 having closed up <Friday> +$0.36;
  • Kite Pharma (KITE) up +$4.28 having closed down <Friday> -$0.72;
  • Spark Therapeutics (ONCE) up +$4.18 having closed down <Friday> -$1.21;
  • Bellicum (BLCM) up +$2.33 having closed down <Friday> -$0.50;
  • Intrexon (XON) up +$1.92 having closed down <Friday> -$0.13;
  • Juno Therapeutics (JUNO) up +$1.90 having closed up <Friday> +$0.37;
  • uniQure (QURE) up +$1.05 having closed down <Friday> -$0.13;
  • Osiris (OSIR) up +$1.05 having closed up <Friday> +$0.60;
  • Applied Genetic Technologies (AGTC) up +$1.03 having closed down <Friday> -$0.08;
  • Regenxbio (RGNX) up +$0.98 having closed down <Friday> -$0.13;
  • Sangamo (SGMO) up +$0.83 having closed down <Friday> +$0.64;
  • Aduro Biotech (ADRO) up +$0.74 having closed up <Friday> +$0.11;
  • Avalanche (AAVL) up +$0.62 having closed down <Friday> +$0.03;
  • MiMedx (MDXG) up +$0.53 having closed down <Friday> -$0.01;
  • Asterias Therapeutics (NYSEMKT: AST) up +$0.50 having closed down <Friday> +$0.33;
  • Fibrocell FCSC) closed UP +$0.46 having closed down <Friday> -$0.28;

 

 

Dosing the sector – what a day for the 43 Patients:

  • Open: POSITIVE with 26 decliners, 12 advances and 5 flats;
  • Mid-day (1 pm): POSITIVE with 25 decliners, 15 advancers and 3 flats;
  • Closing bell: POSITIVE with 1 decliner, 39 advancers and 3 flats

 

 

Monday’s trading indications:  3 hits/ 3 miss

  • Bluebird bio (BLUE) closed UP – hit;
  • Capricor (CAPR) closed UP – miss;
  • Caladrius Bioscience (CLBS) closed UP – miss;
  • MiMedx (MDXG) closed UP – hit;
  • Osiris (OSIR) closed UP – hit;
  • Spark Therapeutics (ONCE) closed UP – miss;

 

 

Riding the indexes and ETFs roller-coaster:

  • The iShares Biotechnology Stocks ETF (IBB) closed UP on Monday +12.60 or +3.87% after Friday’s decline of -3.09 or -0.94%;
  • The NASDAQ Biotechnology index (NBI) closed UP on Monday +131.08 or +3.84% following Friday’s decline of- 31.55 or -0.92%;
  • The Russell 2000 (IWM) closed UP on Monday +2.40 or +2.08% following Friday’s decline of -0.43 or -0.46%;
  • The SPDR SD&P Biotech ETF (XBI) closed UP on Monday +4.48 or +5.72% following Friday’s decline of -0.68 or -1.01%;

 

 

Who closed down – only 1:

  • Brainstorm (BCLI) closed down -$02 to $2.76

 

 

Who was UP – top 5:

  • Bluebird bio (BLUE) closed up +$7.25 to $84.38;
  • Cellectis ADR (CLS) +$4.89 to $31.34;
  • Kite Pharma (KITE) +$4.28 to $72.33;
  • Spark Therapeutics ONCE) +$4.18 to $58.08;
  • Bellicum (BLCM) +$2.33 to $14.88;

 

 

Flat:

  • Mesoblast ADR (USOTC: MBLTY) at $12.33;
  • ReNeuron (RENE.L) at $3.875;
  • VistaGen (VSTA) at $7.49

 

 

All investments are subject to risks. Investors should consider investment objectives. The information included above as well as individual companies and/or securities mentioned should only construed as an indication from any RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.